Toggle visibility Search & Display Options

Select All    Deselect All
 | 
Citations
 | 
   print
Hiltebrand, D., Dey, M., Bolliger, H., & Schaub, M. P. (2017). Traitement avec prescription d’héroïne en suisse : résultats de l’enquête 2016 (Institut suisse de recherche sur la santé publique et les addictions, Ed.). Zurich: Institut suisse de recherche sur la santé publique et les addictions (ISGF).
Toggle visibility
Hiltebrand, D., Dey, M., Mayorova, E., Bolliger, H., & Schaub, M. P. (2016). Traitement avec prescription d’héroïne en suisse : résultats de l’enquête 2015 (Institut suisse de recherche sur la santé publique et les addictions, Ed.). Institut suisse de recherche sur la santé publique et les addictions (ISGF).
Toggle visibility
Hiltebrand, D., Dickson-Spillmann, M., Bolliger, H., & Schaub, M. P. (2015). Traitement avec prescription d'héroïne en Suisse : résultats de l'enquête 2014 (Institut suisse de recherche sur la santé publique et les addictions, Ed.). Zurich: Institut suisse de recherche sur la santé publique et les addictions (ISGF).
Toggle visibility
European Monitoring Centre for Drugs and Drug Addiction. (2011). General report of activities 2010 : including “Annual report of the EMCDDA's authorising officer”. General report of activities. Luxembourg: Office for Official Publications of the European Communities.
Toggle visibility
European Monitoring Centre for Drugs and Drug Addiction. (2012). General report of activities 2011 : key achievements and governance : a year in review. General report of activities. Luxembourg: Office for Official Publications of the European Communities.
Toggle visibility
European Monitoring Centre for Drugs and Drug Addiction. (2012). EMCDDA strategy and work programme 2013-15. Work programmes and strategies. Luxembourg: Publications Office of the European Union.
Toggle visibility
European Monitoring Centre for Drugs and Drug Addiction. (2013). General report of activities 2012 : key achievements and governance : a year in review. General report of activities. Luxembourg: Office for Official Publications of the European Communities.
Toggle visibility
various. (2013). Drugnet Europe No. 82 : Europe's drugs problem in “state of flux”. Drugnet Europe : newsletter of the European Monitoring Centre for Drugs and Drug Addiction, 18(82; 04/2013), 8.
Toggle visibility
various. (2013). Drugnet Europe No. 81 : EU drug markets: a strategic analysis : EU drug markets report : highlights : new EU drug strategy endorsed : EMCDDA embarks on new annual and three-year work programmes : report reveals risks of substance use behind the wheel : upcoming risk assessment on 5-IT : European summer school on illicit drugs : management board re-elects chair and vice-chair. Drugnet Europe : newsletter of the European Monitoring Centre for Drugs and Drug Addiction, 18(81; 02/2013), 8.
Toggle visibility
various. (2012). Drugnet Europe No. 80 : EMCDDA annual report 2012 highlights : 4-MA – new drug under scrutiny in the wake of deaths : record number of online shops selling 'legal highs' : heroin use in decline and shifting patterns of problem drug use : 'testing the waters' : 2013 conference : 2012 EMCDDA scientific paper award winners : new EMCDDA products and services : annual report 2012 (continued). Drugnet Europe : newsletter of the European Monitoring Centre for Drugs and Drug Addiction, 17(80; 11/2012), 8.
Toggle visibility
Select All    Deselect All
 | 
Citations
 | 
   print